1. Tsui, JI, Lira, MC, Cheng, DM, et al. Chronic pain, craving, and illicit opioid use among patients receiving opioid agonist therapy. Drug Alcohol Depend 2016; 166: 26–31.
Google Scholar | Crossref | Medline2. Barry, D, Sullivan, B, Petry, NM. Comparable efficacy of contingency management for cocaine dependence among African American, Hispanic, and White methadone maintenance clients. Psychol Addict Behav 2009; 23(1): 168–174.
Google Scholar | Crossref | Medline3. Rosenblum, A, Joseph, H, Fong, C, et al. Prevalence and characteristics of chronic pain among chemically dependent patients in methadone maintenance and residential treatment facilities. JAMA 2003; 289(18): 2370–2378.
Google Scholar | Crossref | Medline4. Higgins, C, Smith, BH, Matthews, K. Substance misuse in patients who have comorbid chronic pain in a clinical population receiving methadone maintenance therapy for the treatment of opioid dependence. Drug Alcohol Depend 2018; 193: 131–136.
Google Scholar | Crossref | Medline5. Jamison, RN, Kauffman, J, Katz, NP. Characteristics of methadone maintenance patients with chronic pain. J Pain Symptom Manage 2000; 19(1): 53–62.
Google Scholar | Crossref | Medline6. Ilgen, MA, Perron, B, Czyz, EK, et al. The timing of onset of pain and substance use disorders. Am J Addict 2010; 19(5): 409–415.
Google Scholar | Crossref | Medline7. American Psychiatric Association . Diagnostic and statistical manual of mental disorders. 5th ed. Arlington, VA: American Psychiatric Publishing, 2013.
Google Scholar | Crossref8. Ballantyne, JC, LaForge, SK. Opioid dependence and addiction during opioid treatment of chronic pain. Pain 2007; 129(3): 235–255.
Google Scholar | Crossref | Medline9. Chou, R, Ballantyne, J, Lembke, A. Rethinking opioid dose tapering, prescription opioid dependence, and indications for buprenorphine. Ann Intern Med 2019; 171(6): 427–429.
Google Scholar | Crossref | Medline10. Weissman, DE, Haddox, DJ. Opioid pseudoaddiction – an iatrogenic syndrome. Pain 1989; 36(3): 363–366.
Google Scholar | Crossref | Medline11. Manhapra, A, Sullivan, MD, Ballantyne, JC, et al. Complex persistent opioid dependence with long-term opioids: a gray area that needs definition, better understanding, treatment guidance, and policy changes. J Gen Intern Med 2020; 35(Suppl. 3): 964–971.
Google Scholar | Crossref | Medline12. Velayudhan, A, Bellingham, G, Morley-Forster, P. Opioid-induced hyperalgesia. BJA Educ 2014; 14(3): 125–129.
Google Scholar13. Higgins, C, Smith, BH, Matthews, K. Evidence of opioid-induced hyperalgesia in clinical populations after chronic opioid exposure: a systematic review and meta-analysis. Br J Anaesth 2019; 122(6): e114–e126.
Google Scholar | Crossref | Medline14. National Institute on Drug Abuse (NIDA) . Health consequences of drug misuse, https://www.drugabuse.gov/related-topics/health-consequences-drug-misuse (2020, accessed 8 August 2020).
Google Scholar15. Voon, P, Hayashi, K, Milloy, MJ, et al. Pain among high-risk patients on methadone maintenance treatment. J Pain 2015; 16(9): 887–894.
Google Scholar | Crossref | Medline16. Cushman, P . The major medical sequelae of opioid addiction. Drug Alcohol Depend 1980; 5(4): 239–254.
Google Scholar | Crossref | Medline17. Smith, BH, Torrance, N. Epidemiology of chronic pain. In: McQuay, HJ, Kalso, E, Moore, RA (eds) Systematic reviews in pain research: methodology refined. Seattle, WA: IASP Press, pp. 247–273, 2008.
Google Scholar18. Higgins, C, Smith, BH, Matthews, K. Comparison of psychiatric comorbidity in treatment-seeking, opioid-dependent patients with versus without chronic pain. Addiction 2020; 115(2): 249–258.
Google Scholar | Crossref | Medline19. Cleeland, CS, Ryan, KM. Pain assessment: global use of the brief pain inventory. Ann Acad Med Singap 1994; 23(2): 129–138.
Google Scholar | Medline20. Tan, G, Jensen, MP, Thornby, JI, et al. Validation of the brief pain inventory for chronic nonmalignant pain. J Pain 2004; 5(2): 133–137.
Google Scholar | Crossref | Medline | ISI21. Dennis, BD, Roshanov, PS, Bawor, M, et al. Usefulness of the brief pain inventory in patients with opioid addiction receiving methadone maintenance treatment. Pain Physician 2016; 19(1): E181–E195.
Google Scholar | Medline22. Marsden, J, Gossop, G, Stewart, D, et al. The Maudsley Addiction Profile (MAP): a brief instrument for assessing treatment outcome. Addiction 1998; 93(12): 1857–1867.
Google Scholar | Crossref | Medline | ISI23. Goldberg, DP, Hillier, VF. A scaled version of the General Health Questionnaire. Psychol Med 1979; 9(1): 139–145.
Google Scholar | Crossref | Medline | ISI24. Goldberg, DP, Gater, R, Sartorius, N, et al. The validity of two versions of the GHQ in the WHO study of mental illness in general health care. Psychol Med 1997; 27(1): 191–197.
Google Scholar | Crossref | Medline | ISI25. Pérez-Moreno, P, Lozano, O, Rojas-Tejada, AJ. Propiedades psicométricas del GHQ-28 en pacientes con dependencia a opiáceos (Psychometric properties of the GHQ-28 in opiate-dependent patients). Adicciones 2010; 22(1): 65–72.
Google Scholar | Crossref | Medline26. Evans, C, Mellor-Clark, J, Margison, F, et al. CORE: clinical outcomes in routine evaluation. J Ment Health 2000; 9(3): 247–255.
Google Scholar | Crossref27. Barkham, M, Mellor-Clark, J, Connell, J, et al. A core approach to practice-based evidence: a brief history of the origins and applications of the CORE-OM and CORE System. Couns Psychother Res 2006; 6(1): 3–15.
Google Scholar | Crossref28. Newman, MG, Kachin, KE, Zuellig, AR, et al. The Social Phobia Diagnostic Questionnaire: preliminary validation of a new self-report diagnostic measure of social phobia. Psychol Med 2003; 33(4): 623–635.
Google Scholar | Crossref | Medline29. Marsden, J, Stewart, D, Gossop, M, et al. Assessing client satisfaction with treatment for substance use problems and the development of the treatment perceptions questionnaire (TPQ). Addict Res Theory 2000; 8(5): 455–470.
Google Scholar | Crossref30. American Pain Society . Principles of analgesic use in the treatment of acute pain and cancer pain. 6th ed. Glenview, IL: American Pain Society, 2008.
Google Scholar31. Anderson, R, Saiers, JH, Abram, S, et al. Accuracy in equianalgesic dosing: conversion dilemmas. J Pain Symptom Manage 2001; 21(5): 397–406.
Google Scholar | Crossref | Medline | ISI32. Pereira, J, Lawlor, P, Vigano, A, et al. Equianalgesic dose ratios for opioids. a critical review and proposals for long-term dosing. J Pain Symptom Manage 2001; 22(2): 672–687.
Google Scholar | Crossref | Medline | ISI33. Patanwala, AE, Duby, J, Waters, D, et al. Opioid conversions in acute care. Ann Pharmacother 2007; 41(2): 255–266.
Google Scholar | SAGE Journals | ISI34. Handelsman, L, Aronson, MJ, Ness, R, et al. The dysphoria of heroin addiction. Am J Drug Alcohol Abuse 1992; 18(3): 275–287.
Google Scholar | Crossref | Medline35. Janiri, L, Martinotti, G, Dario, T, et al. Anhedonia and substance-related symptoms in detoxified substance-dependent subjects: a correlation study. Neuropsychobiology 2005; 52(1): 37–44.
Google Scholar | Crossref | Medline36. Lazaridou, A, Paschali, M, Edwards, RR, et al. Is buprenorphine effective for chronic pain? A systematic review and meta-analysis. Pain Med 2020; 21(12): 3691–3699.
Google Scholar | Crossref | Medline37. Tsai, AC, Kiang, MV, Barnett, ML, et al. Stigma as a fundamental hindrance to the United States opioid overdose crisis response. PLoS Med 2019; 16(11): e1002969.
Google Scholar | Crossref | Medline